⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMIX News
Autonomix Medical, Inc. Common Stock
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
globenewswire.com
AMIX
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
globenewswire.com
AMIX
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
globenewswire.com
AMIX
Form 8-K
sec.gov
AMIX
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
globenewswire.com
AMIX
MDT
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
globenewswire.com
AMIX
Form 8-K
sec.gov
AMIX
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
globenewswire.com
AMIX
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
globenewswire.com
AMIX
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
globenewswire.com
AMIX